FDA takes next step in Tor­rent Phar­ma­ceu­ti­cal­s' trou­bled In­dia plant saga, is­sues OAI

The FDA has hand­ed Tor­rent Phar­ma­ceu­ti­cals an of­fi­cial ac­tion in­di­cat­ed (OAI) sta­tus for a pre­vi­ous­ly in­spect­ed man­u­fac­tur­ing fa­cil­i­ty in In­dia.

Tor­rent Phar­ma sent a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER